Background: The post-acute sequelae of SARS-CoV-2 infection represent a growing public health concern. While associations between COVID-19 and metabolic disorders have been reported, less is known about this risk in young, healthy populations. This study aimed to quantify the risk of developing new-onset metabolic disorders following SARS-CoV-2 infection among U.S. active-duty service members. Methods: We conducted a propensity score-matched cohort study using U.S. Military Health System data between July 2020 and June 2021 of active-duty service members (ADSM) aged 18 to 65 years old. COVID-19 infections were identified through ICD-10 codes or laboratory results. A 1:2 matched cohort compared 103,789 COVID-19 exposed individuals with 207,578 controls. Outcomes included incident diagnoses of type 2 diabetes mellitus (T2DM), hypertension (HTN), hyperlipidemia (HLD), metabolic dysfunction-associated steatotic liver disease (MASLD), and metabolic syndrome (MetS) within one year. Cox proportional hazards models calculated adjusted hazard ratios (aHR) while controlling for obesity and overweight status. Results: The median age for both those with and without COVID-19 infection was 26 years (interquartile range 22–33 years), with males comprising the majority of participants (81.1% male, 18.9% female). COVID-19 infection was associated with significantly increased hazards for incident HTN (aHR 1.09; 95% CI, 1.01–1.18), HLD (aHR 1.30; 95% CI, 1.10–1.54), and MASLD (aHR 1.36; 95% CI, 1.15–1.60). However, no significant increased risk was observed for T2DM or MetS. Conclusions: COVID-19 infection was associated with significantly increased risk of developing HTN, HLD, and MASLD, highlighting important long-term metabolic consequences in a young, healthy population.
To identify whether a relationship exists between COVID-19 and appendicitis and compare the incidence of appendicitis during three pandemic years to the year prior to the pandemic, we conducted two observational retrospective studies: a propensity score-matched (PSM) cohort and a repeated monthly cross-sectional study. We used data from the Military Health System (MHS) Data Repository, which contains data about healthcare provided to active-duty service members, retirees, and their dependents. For the PSM cohort of 753,138 individuals, patients with COVID-19 between July 2020 and June 2021 from the MHS were matched to two similar people without COVID-19. Survival analysis using a conditional Cox proportional hazards model explored these relationships. For the cross-sectional study we used a separate, unmatched MHS cohort of 10,402,021 individuals. Poisson regression generated incident rate ratios (IRRs) of any appendicitis or complicated appendicitis by year, comparing three pandemic years to one pre-pandemic year. COVID-19 was associated with appendicitis or appendectomy within the first year of infection (hazard ratio: 1.13, 95% confidence interval: 1.02–1.26). The IRRs for both any appendicitis and complicated appendicitis were significantly less than one when comparing individual pandemic years to the pre-pandemic year. COVID-19 is associated with appendicitis. Rates of any appendicitis and complicated appendicitis were lower in each individual pandemic year.
The long-term neuropsychiatric effects of COVID-19 are still unclear. Various mental health conditions are known to be influenced by biopsychosocial factors. We sought to investigate whether COVID-19 infection increases the risk for newly diagnosed anxiety, mood, or trauma and stressor-related disorders in individuals ages 12–64 years. We performed a retrospective cohort study using data from the Military Health System database (2018–2022). A propensity score match pairing each person with a COVID-19 diagnosis to two uninfected individuals was implemented, balancing matches across 1852 different variables representing medical records of procedures, diagnoses, and prescriptions in the year prior to COVID-19 infection. Exact matching was performed on sex, age in years, beneficiary type and month of entry into the cohort. We calculated the hazard ratios (HR) and Bonferroni-corrected confidence intervals (BoCI) for new mental health diagnoses using the Cox proportional hazards models. The initial matched cohort included 788,185 individuals. COVID-19 significantly increased the risk for newly diagnosed mental health conditions. The effect was strongest for trauma and stressor-related disorders (HR, 1.29; BoCI, 1.22–1.37), followed by mood disorders (HR, 1.22; BoCI, 1.15–1.30) and anxiety disorders (HR, 1.16; BoCI, 1.12–1.21). COVID-19 infection is associated with the subsequent diagnosis of a new mental health condition, including depressive, trauma and stressor-related, mood, and anxiety disorders. Our findings suggest that screening for mental health conditions should be a key part of post-COVID-19 care, and more work is needed to understand the biological reasons for this connection and consider the role of vaccines for prevention.
Background: Post-COVID-19 conditions (PCCs) present a significant public health challenge due to a vast array of new or persistent health symptoms across subjects. The complex, multi-systemic nature of PCCs makes these conditions difficult to differentiate from other non-COVID-19 related medical conditions. While the Military Health System Data Repository (MDR) provides a robust supply of population-level encounter data, its high-dimensional structure poses challenges for knowledge discovery and outcome research. Objectives: The primary aim of this study was to identify novel manifestations of PCCs among active-duty service members, and model the probabilistic relationships between PCC-related diagnoses. We propose a machine learning workflow as an effective tool for knowledge discovery to statistically validate candidate PCCs from large datasets. Methods: We conducted a retrospective cohort study using MDR records from July 2018 to June 2023. From an initial pool of 311,367 eligible Active-Duty Tricare beneficiaries, we isolated 101,789 COVID-19 infections and matched them 1:1 with uninfected controls (N = 203,578 total) based on age, sex, and propensity for COVID-19. Encounter data was mapped to 392 clinical categories using the Healthcare Cost and Utilization Project (HCUP) Clinical Classification Software Refined (CCSR). Candidate PCC categories were isolated using a cross-validated lasso regression model optimized with a Tree of Parzen Estimators algorithm. A consensus Bayesian Network structure was fitted to model potential probabilistic dependency structures between identified PCCs and prior COVID-19 diagnosis. Finally, conditional Cox proportional hazards models were used to statistically validate selected novel conditions using larger cohorts drawn from the same initial eligible pool by matching cases 1:2 with controls. Results: Feature selection reduced the diagnosis set by 97.96%, isolating 8 clinical categories from the initial 392. The model confirmed known PCCs, such as respiratory symptoms and malaise, and identified two potentially novel candidate PCCs: tinnitus and personality disorders. Survival analysis validated the selection of tinnitus, showing a significant association with COVID-19 (HR: 1.17, 95% CI: 1.12–1.22). No significant association was found between COVID-19 infection and personality disorders (HR: 1.11, 95% CI: 0.97–1.26). Conclusions: This study demonstrates an effective analytical pathway for addressing the limitations of analyzing complex, high-dimensional healthcare billing data. The methodology successfully generated testable hypotheses, identifying tinnitus as a relevant sequela, and is generalizable to future research involving unknown health outcomes related to prior infection.